Intrinsic value of GMO Emerging Markets R6 (GEMNX)
Live fair value data for GMO Emerging Markets R6 (GEMNX) is currently unavailable. Please check again shortly.
Current Price: $213.00
Valuation: Undervalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is GMO Emerging Markets R6 (GEMNX) undervalued or overvalued?
Based on the current model output, GMO Emerging Markets R6 appears to be undervalued with a upside of 16.00%.
Fair value vs market price — GMO Emerging Markets R6 (GEMNX)
Unlock premium access to view the live fair value comparison against current market price for GEMNX.
Frequently Asked Questions - GEMNX
How is GEMNX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for GEMNX.
Is GEMNX undervalued or overvalued right now?
GEMNX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for GEMNX: open their intrinsic value pages.
- FSRBXFidelity Select Banking Portfolio
- EXHAXManning & Napier Fd, Inc. Pro-Blend Maximum Term Srs Cl S
- STSGXAmerican Beacon Stephens Small Cap Growth Fd Inv Cl
- MIQBXMSIF International Equity Class A
- MMacy's, Inc.
- EEni S.p.A.
- GTLIXGlenmede Quantitative U.S. Large Cap Core Equity Portfolio
- ARGVXOne Choice 2060 Portfolio - Investor Class